All Stories

  1. Editorial (Thematic Issue: Lipid-Based Nanoformulations for Active Delivery)
  2. Folate Receptor Targeted Liposomes Encapsulating Anti-Cancer Drugs
  3. Potentials of Polymeric Nanoparticle as Drug Carrier for Cancer Therapy: With a Special Reference to Pharmacokinetic Parameters
  4. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers: I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles
  5. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers: II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations
  6. Chitosan Derivatives for Oral Delivery of Insulin
  7. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
  8. Development and In Vitro Evaluations of a Lipid Nanoparticle Formulation Containing Tretinoin
  9. Preparation and physicochemical characterization of trans-resveratrol nanoparticles by temperature-controlled antisolvent precipitation
  10. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: Effects of process variables
  11. QUANTIFICATION OFTRANS-RESVERATROL IN RAT PLASMA BY A SIMPLE AND SENSITIVE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD AND ITS APPLICATION IN PRE-CLINICAL STUDY
  12. Polyethyleneimine-modified pectin beads for colon-specific drug delivery:In vitroandin vivoimplications
  13. Formulation, Biological and Pharmacokinetic Studies of Sucrose Ester-Stabilized Nanosuspensions of Oleanolic Acid
  14. Preparation and evaluation of zinc–pectin–chitosan composite particles for drug delivery to the colon: Role of chitosan in modifying in vitro and in vivo drug release
  15. Recent Advancement of Chitosan-Based Nanoparticles for Oral Controlled Delivery of Insulin and Other Therapeutic Agents
  16. Impact of Glutaraldehyde on In Vivo Colon-Specific Release of Resveratrol from Biodegradable Pectin-Based Formulation
  17. Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol:In vitroandin vivoevaluations
  18. Formulation and Optimization of Zinc-Pectinate Beads for the Controlled Delivery of Resveratrol
  19. Resveratrol-loaded calcium-pectinate beads: Effects of formulation parameters on drug release and bead characteristics
  20. Colon-specific delivery of resveratrol: Optimization of multi-particulate calcium-pectinate carrier
  21. The Impact of Aqueous Solubility and Dose on the Pharmacokinetic Profiles of Resveratrol
  22. The Impact of Aqueous Solubility and Dose on the Pharmacokinetic Profiles of Resveratrol